What does interstitial lung disease (ILD) look like on imaging?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Imaging Appearance of Interstitial Lung Disease

Interstitial lung disease appears on high-resolution CT (HRCT) as bilateral abnormalities involving >5% of total lung volume, characterized by ground-glass opacities, reticular patterns, traction bronchiectasis, and/or honeycombing, with distribution patterns that help distinguish specific ILD subtypes. 1

Key Imaging Features by Pattern

Usual Interstitial Pneumonia (UIP) Pattern

The UIP pattern is the hallmark of idiopathic pulmonary fibrosis and appears with specific features:

  • Subpleural and basal predominant distribution with patchy involvement 1
  • Honeycombing consisting of clustered cystic airspaces with thick walls, typically in subpleural regions 1
  • Reticular opacities with traction bronchiectasis indicating architectural distortion 1
  • Absence of features inconsistent with UIP, such as predominant ground-glass opacities, mosaic attenuation, or centrilobular nodules 1

Fibrotic Hypersensitivity Pneumonitis Pattern

Fibrotic HP demonstrates a distinct constellation of findings:

  • Profuse poorly defined ground-glass centrilobular nodules scattered throughout the lungs 1
  • Three-density sign showing areas of normal lung, ground-glass opacity, and air trapping on expiratory imaging 1
  • Mosaic attenuation pattern with air trapping on expiratory sequences 1
  • Upper and mid-lung zone predominance in many cases, though distribution can be variable 1

Interstitial Lung Abnormalities (ILA) Subtypes

ILAs represent early or limited disease involving ≤5% of a lung zone and are categorized into three subtypes: 1

Nonsubpleural ILA

  • Patchy ground-glass and peribronchovascular opacities predominantly in upper lung zones 1
  • Minimal reticular opacities without architectural distortion 1

Subpleural Nonfibrotic ILA

  • Bilateral subpleural reticulations without traction bronchiectasis or honeycombing 1
  • Absence of architectural distortion distinguishing it from fibrotic disease 1

Fibrotic ILA

  • Bilateral subpleural reticulations with traction bronchiolectasis indicating early fibrosis 1
  • Architectural distortion present but involving <5% of total lung volume 1

Progression to Definite ILD

When imaging abnormalities meet specific thresholds, ILA transitions to definite ILD:

  • Fibrotic abnormalities involving ≥5% of total lung volume by visual estimate, defined by honeycombing and/or reticulation with traction bronchiectasis 1
  • Progressive fibrotic abnormality on serial chest CT demonstrating interval worsening 1
  • Presence of a major fibrotic ILD pattern including UIP/probable UIP, fibrotic HP, or fibrotic NSIP regardless of extent 1

Imaging Modality Recommendations

HRCT as Gold Standard

HRCT is the definitive imaging modality for ILD evaluation:

  • HRCT has 95.7% sensitivity and 63.8% specificity for detecting ILD with ≥20% lung involvement 2
  • Chest radiography alone is insufficient, as up to 10% of ILD patients have normal chest X-rays 2
  • HRCT should include inspiratory prone images and supine end-expiratory imaging to distinguish true abnormalities from dependent atelectasis 1, 2

Role of Other Modalities

  • CT with IV contrast serves no purpose in suspected ILD evaluation 1
  • MRI has limited utility and has not been validated for routine ILD diagnosis 1
  • FDG-PET/CT is not indicated for initial ILD evaluation 1

Common Pitfalls and Caveats

Several imaging findings require careful interpretation to avoid misdiagnosis:

  • Dependent ground-glass opacities on supine imaging may represent atelectasis rather than true pathology—confirm persistence on prone imaging 1, 3
  • Isolated reticulation without traction bronchiectasis is a risk factor for progression but insufficient for ILD diagnosis unless progression is documented 1
  • Bronchiolectasis alone (dilation of bronchioles within central portions of secondary pulmonary lobule) is less prognostically informative and not included in ILD definition 1
  • UIP pattern can occur in non-IPF diagnoses including connective tissue disease-ILD, fibrotic HP, and asbestosis—clinical context is essential 1

Distinguishing Features for Specific Diagnoses

Additional imaging clues help identify underlying etiology:

  • Exuberant honeycombing, anterior upper lobe involvement, or straight-edge sign suggest connective tissue disease-ILD 1
  • Bilateral pleural plaques indicate asbestos exposure 1
  • Dilated esophagus or osseous erosions suggest systemic sclerosis 1
  • Well-demarcated preserved lobules with intervening ground-glass opacities favor hypersensitivity pneumonitis over IPF 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Diagnosis and Management of Interstitial Lung Disease

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Evaluation and Management of Bilateral Pulmonary Ground Glass Opacities

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.